Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Milestone Medical Inc. [Member]        
Income (Loss) from Equity Method Investments $ (590,612) $ (1,566,711)
Income (loss) in equity investments (590,612) (1,566,711)
Milestone Education LLC [Member]        
Income (Loss) from Equity Method Investments 2,343 (5,493)
Income (loss) in equity investments 2,343 (5,493)
Milestone China [Member]        
Income (Loss) from Equity Method Investments (253,451) (123,083) (554,766) (187,062)
Income (loss) in equity investments (253,451) (123,083) (554,766) (187,062)
Product sales, net 3,186,596 2,459,958 8,973,726 6,996,921
Cost of products sold 1,517,561 794,285 3,675,552 2,298,162
Gross profit 1,669,035 1,665,673 5,298,174 4,698,759
Selling, general and administrative expenses 2,933,950 2,480,354 9,226,062 6,969,332
Research and development expenses 303,268 20,676 756,045 49,616
Total operating expenses 3,237,218 2,501,030 9,982,107 7,018,948
Loss from operations (1,568,183) (835,357) (4,683,933) (2,320,189)
Interest expense (846) (1,043) (2,782) (961)
Loss before provision for income tax and equity in net earnings of equity investments (1,569,029) (836,400) (4,686,715) (2,321,150)
Provision for income tax (16,522) (27,105) (80,147) (40,751)
Loss before equity in net earnings of equity investments (1,585,551) (863,505) (4,766,862) (2,361,901)
Income (Loss) from Equity Method Investments (253,451) (711,352) (554,766) (1,759,266)
Income (loss) in equity investments (253,451) (711,352) (554,766) (1,759,266)
Net Loss (1,839,002) (1,574,857) (5,321,628) (4,121,167)
Net loss attributable to noncontrolling interests (137,752) (5,655) (1,113,958) (59,642)
Net loss attributable to Milestone Scientific Inc. $ (1,701,250) $ (1,569,202) $ (4,207,670) $ (4,061,525)
Net loss per share applicable to common stockholders—        
Basic (in dollars per share) $ (0.05) $ 0.07 $ (0.16) $ (0.19)
Diluted (in dollars per share) $ (0.05) $ (0.07) $ (0.16) $ (0.19)
Weighted average shares outstanding and to be issued—        
Basic (in shares) 29,155,712 21,418,145 25,965,566 21,375,317
Diluted (in shares) 29,155,712 21,418,145 25,965,566 21,375,317